Camillo Porta

25PUBLICATIONS
98CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 28, 2026
Overlapping roles of dysregulated glycolysis in the pathophysiology of diabetes and cancer.

|Jan 23, 2026
Identification of Predictive Genomic Biomarkers in Metastatic Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis of Real-World Clinicogenomic Data.

Mimma Rizzo, Gaetano Pezzicoli, Camilla Porta

|Nov 14, 2025
Two-Stage Estimation of Overall Survival in the Phase 3 CheckMate 9ER Trial, Adjusting for the Impact of Subsequent Therapy.

Marc-Oliver Grimm, Emma Karim, Venediktos Kapetanakis

|Mar 11, 2023
Melanoma Brain Metastases: A Retrospective Analysis of Prognostic Factors and Efficacy of Multimodal Therapies.

Valeria Internò, Maria Chiara Sergi, Maria Elvira Metta

|Sep 28, 2022
Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury.

Ben Sprangers, David E Leaf, Camillo Porta

|Jun 08, 2022
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).

Caterina Caminiti, Jane Bryce, Silvia Riva

Pageof 5

Frequent Collaborators

5 joint publications

Mimma Rizzo

3 joint publications

Pasquale Ditonno

3 joint publications

Giuseppe Lucarelli

2 joint publications

Juan Lucio Iovanna